Analysis of the association of TFPI-2 promoter hypermethylation and clinico-pathological parameters of NPC patients revealed no significant association of presence of methylated or unmethylated TFPI-2 promoters and age, sex, cancer staging, or pathological subtypes (Table 1). The gene discussed is TFPI2; the disease is nasopharyngeal carcinoma.